Inhibikase Therapeutics Inc Stock, NASDAQ:IKT
3350 Riverwood Parkway, Suite 1900, Atlanta, Georgia 30339
United States of America
Number of Employees: 6
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMPâ„¢ Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.